Published by Josh White on 9th January 2024
(Sharecast News) - Faron Pharmaceuticals has initiated phase two of the BEXMAB trial, it announced on Tuesday, marking a significant milestone in its cancer treatment development programme.
URL: http://www.digitallook.com/dl/news/story/34013369/...